A new facet of NDRG1 in pancreatic ductal adenocarcinoma: Suppression of glycolytic metabolism
Wensheng Liu(The University of Sydney), Jin Xu(Fudan University Shanghai Cancer Center)
Cited by 26
Related Papers
New observations on the utility of CA19-9 as a biomarker in Lewis negative patients with pancreatic cancer
|Pancreatology|2018|79
The proto-oncogene c-Src and its downstream signaling pathways are inhibited by the metastasis suppressor, NDRG1
|Oncotarget|2015|75
The combination of systemic inflammation-based marker NLR and circulating regulatory T cells predicts the prognosis of resectable pancreatic cancer patients
|Pancreatology|2016|65
Epithelial–mesenchymal transition in pancreatic cancer: Is it a clinically significant factor?
|Biochimica et Biophysica Acta (BBA) - Reviews on Cancer|2014|42
Silencing of MBD1 reverses pancreatic cancer therapy resistance through inhibition of DNA damage repair
|International Journal of Oncology|2013|28